HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
methyl 2-{2-[4-(1H-indol-3-yl)-piperidin-1-yl]-ethoxy}-benzoate → 2-(2-{4-[1-(tetrahydro-furan-3-ylmethyl)-1H-indol-3-yl)-piperidin-1-yl}-ethoxy)-benzoic Acid
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | methyl 2-{2-[4-(1H-indol-3-yl)-piperidin-1-yl]-ethoxy}-benzoate | HCID 11440344 | — |
| Edukt | (Tetrahydrofuran-3-yl)methyl methanesulfonate | HCID 22273010 | — |
| Produkt | 2-(2-{4-[1-(tetrahydro-furan-3-ylmethyl)-1H-indol-3-yl)-piperidin-1-yl}-ethoxy)-benzoic Acid | HCID 10138673 | — |
Reaktionsschritte
This compound was prepared following the procedure described in example 1 (part E) starting with 0.1 g (0.26 mmol) of 2-{2-[4-(1H-indol-3-yl)-piperidin-1-yl]-ethoxy}-benzoic acid methyl ester and 0.067 g (0.37 mmol) of freshly prepared tetrahydro-furan-3-ylmethyl methanesulfonate. After standard purification, 0.045 g (39% of yield) of the expected acid were obtained.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US07189741B2 |
| Quelldatensatz | uspto-grants-2007_03 |
| ORD ID | ord-fddf8f7659664d49accf6d1111ea3921 |
| Quellennotiz | uspto-grants-2007_03 |